Chromosome 1 open reading frame 190 promotes activation of NF-κB canonical pathway and resistance of dendritic cells to Tumor-associated inhibition in vitro

Journal of Immunology

Volumn 185, Issue 11, 2010, Pages 6719-6727

  Zhizi, Jing ^a   Xin, Yuan ^a   Jing, Zhang ^a   Xin, Huang ^a   Zhiqian, Zhang ^a   Jingyi, Liu ^a   Miaomiao, Zhang ^a   Jiangbo, Oyang ^a   Yuan, Zhang ^a   Zhujun, Zhang ^a   Rongcun, Yang ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CHROMOSOME 1; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; OPEN READING FRAME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR IMMUNITY;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; CELL LINE; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 1; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DIMERIZATION; FEMALE; HELA CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; OVARIAN NEOPLASMS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 78650657075     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903869     Document Type: Article

References (41)

1. Steinman, R. M., D. Hawiger, K. Liu, L. Bonifaz, D. Bonnyay, K. Mahnke, T. Iyoda, J. Ravetch, M. Dhodapkar, K. Inaba, and M. Nussenzweig. 2003. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. N. Y. Acad. Sci. 987:15-25.
2. Ardeshna, K. M., A. R. Pizzey, S. Devereux, and A. Khwaja. 2000. The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocytederived dendritic cells. Blood 96:1039-1046.
3. Rescigno, M., M. Martino, C. L. Sutherland, M. R. Gold, and P. Ricciardi-Castagnoli. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188:2175-2180.
4. Andreakos, E., C. Smith, C. Monaco, F. M. Brennan, B. M. Foxwell, and M. Feldmann. 2003. IkB kinase 2 but not NF-kB-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction. Blood 101:983-991.
5. Yoshimura, S., J. Bondeson, B. M. Foxwell, F. M. Brennan, and M. Feldmann. 2001. Effective antigen presentation by dendritic cells is NF-kB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int. Immunol. 13:675-683.
6. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kB/Rel family. Cell 80:331-340.
7. Oyama, T., S. Ran, T. Ishida, S. Nadaf, L. Kerr, D. P. Carbone, and D. I. Gabrilovich. 1998. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kB activation in hemopoietic progenitor cells. J. Immunol. 160:1224-1232.
8. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-kB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
9. Silverman, N., and T. Maniatis. 2001. NF-kB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15:2321-2342.
10. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109 (Suppl.): S81-S96.
11. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
12. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87:13-20.
13. Barkett, M., and T. D. Gilmore. 1999. Control of apoptosis by Rel/NF-kB transcription factors. Oncogene 18:6910-6924.
14. Verma, I. M., and J. Stevenson. 1997. IκB kinase: beginning, not the end. Proc. Natl. Acad. Sci. USA 94:11758-11760.
15. Senftleben, U., Y. Cao, G. Xiao, F. R. Greten, G. Krähn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S. C. Sun, and M. Karin. 2001. Activation by IKKa of a second, evolutionary conserved, NF-κB signaling pathway. Science 293:1495-1499.
16. Sun, S. C., and G. Xiao. 2003. Deregulation of NF-kB and its upstream kinases in cancer. Cancer Metastasis Rev. 22:405-422.
17. Rongcun, Y., H. Maes, M. Corsi, F. Dellner, T. Wen, and R. Kiessling. 1998. Interferon g impairs the ability of monocyte-derived dendritic cells to present tumour-specific and allo-specific antigens and reduces their expression of CD1A, CD80 and CD4. Cytokine 10:747-755.
18. Rongcun, Y., F. Salazar-Onfray, J. Charo, K. J. Malmberg, K. Evrin, H. Maes, K. Kono, C. Hising, M. Petersson, O. Larsson, et al. 1999. Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas. J. Immunol. 163:1037-1044.
19. Yang, R., F. M. Murillo, H. Cui, R. Blosser, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. Roden. 2004. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce a interferon and Th1 immune responses via MyD88. J. Virol. 78:11152-11160.
20. Tas, S. W., M. J. Vervoordeldonk, N. Hajji, J. H. Schuitemaker, K. F. van der Sluijs, M. J. May, S. Ghosh, M. L. Kapsenberg, P. P. Tak, and E. C. de Jong. 2007. Noncanonical NF-kB signaling in dendritic cells is required for indoleamine 2, 3-dioxygenase (IDO) induction and immune regulation. Blood 110:1540-1549.
21. May, M. J., F. D'Acquisto, L. A. Madge, J. Glöckner, J. S. Pober, and S. Ghosh. 2000. Selective inhibition of NF-kB activation by a peptide that blocks the interaction of NEMO with the IkB kinase complex. Science 289:1550-1554.
22. Romero, P., D. Valmori, M. J. Pittet, A. Zippelius, D. Rimoldi, F. Lévy, V. Dutoit, M. Ayyoub, V. Rubio-Godoy, O. Michielin, et al. 2002. Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. Immunol. Rev. 188:81-96.
23. Mazzocchi, A., C. Melani, L. Rivoltini, C. Castelli, M. del Vecchio, C. Lombardo, M. P. Colombo, and G. Parmiani. 2001. Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes. Cancer Immunol. Immunother. 50:199-211.
24. Pinna, L. A. 1990. Casein kinase 2: an "eminence grise" in cellular regulation? Biochim. Biophys. Acta 1054:267-284.
25. Woodgett, J. R., K. L. Gould, and T. Hunter. 1986. Substrate specificity of protein kinase C: use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. Eur. J. Biochem. 161:177-184.
26. Kishimoto, A., K. Nishiyama, H. Nakanishi, Y. Uratsuji, H. Nomura, Y. Takeyama, and Y. Nishizuka. 1985. Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 39:59-monophosphate-dependent protein kinase. J. Biol. Chem. 260:12492-12499.
27. Glass, D. B., M. R. el-Maghrabi, and S. J. Pilkis. 1986. Synthetic peptides corresponding to the site phosphorylated in 6-phosphofructo-2-kinase/ fructose-2, 6-bisphosphatase as substrates of cyclic nucleotide-dependent protein kinases. J. Biol. Chem. 261:2987-2993.
28. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
29. Kobie, J. J., R. S. Wu, R. A. Kurt, S. Lou, M. K. Adelman, L. J. Whitesell, L. V. Ramanathapuram, C. L. Arteaga, and E. T. Akporiaye. 2003. Transforming growth factor b inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines. Cancer Res. 63:1860-1864.
30. Chaux, P., M. Moutet, J. Faivre, F. Martin, and M. Martin. 1996. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab. Invest. 74:975-983.
31. Gabrilovich, D. I., I. F. Ciernik, and D. P. Carbone. 1996. Dendritic cells in antitumor immune responses, I: Defective antigen presentation in tumor-bearing hosts. Cell. Immunol. 170:101-110.
32. Brown, K. D., E. Claudio, and U. Siebenlist. 2008. The roles of the classical and alternative nuclear factor-κB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res. Ther. 10:212.
33. Tas, S. W., E. C. de Jong, N. Hajji, M. J. May, S. Ghosh, M. J. Vervoordeldonk, and P. P. Tak. 2005. Selective inhibition of NF-κB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization. Eur. J. Immunol. 35:1164-1174.
34. Ogata, M., Y. Zhang, Y. Wang, M. Itakura, Y. Y. Zhang, A. Harada, S. Hashimoto, and K. Matsushima. 1999. Chemotactic response toward chemokines and its regulation by transforming growth factor-β1 of murine bone marrow hematopoietic progenitor cell-derived different subset of dendritic cells. Blood 93:3225-3232.
35. Brennan, F. R., and G. Dougan. 2005. Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies. Vaccine 23:3210-3222.
36. Tan, P. H., P. Sagoo, C. Chan, J. B. Yates, J. Campbell, S. C. Beutelspacher, B. M. Foxwell, G. Lombardi, and A. J. George. 2005. Inhibition of NF-kB and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J. Immunol. 174:7633-7644.
37. Tomasoni, S., S. Aiello, L. Cassis, M. Noris, L. Longaretti, R. A. Cavinato, N. Azzollini, A. Pezzotta, G. Remuzzi, and A. Benigni. 2005. Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells. Transplantation 79:1056-1061.
38. Dejardin, E., N. M. Droin, M. Delhase, E. Haas, Y. Cao, C. Makris, Z. W. Li, M. Karin, C. F. Ware, and D. R. Green. 2002. The lymphotoxin-b receptor induces different patterns of gene expression via two NF-kB pathways. Immunity 17:525-535.
39. Lawrence, T., M. Bebien, G. Y. Liu, V. Nizet, and M. Karin. 2005. IKKa limits macrophage NF-kB activation and contributes to the resolution of inflammation. Nature 434:1138-1143.
40. Li, Q., Q. Lu, V. Bottero, G. Estepa, L. Morrison, F. Mercurio, and I. M. Verma. 2005. Enhanced NF-kB activation and cellular function in macrophages lacking IkB kinase 1 (IKK1). Proc. Natl. Acad. Sci. USA 102:12425-12430.
41. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146.